EU Probing J&J's $400M Deal For Takeda's Surgical Patch
By Matthew Perlman ( March 25, 2020, 4:54 PM EDT) -- Europe's competition enforcer opened an in-depth investigation on Wednesday into Johnson & Johnson's planned $400 million purchase of a surgical patch from Takeda Pharmaceuticals to examine concerns about the potential impact on products sold to manage bleeding....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.